Advertisement

Platelet-Activating Factor (PAF): Signalling and Adhesion in Cell-Cell Interactions

  • G. A. Zimmerman
  • M. R. Elstad
  • D. E. Lorant
  • T. M. McIntyre
  • S. M. Prescott
  • Matthew K. Topham
  • A. S. Weyrich
  • Ralph E. Whatley
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 416)

Abstract

PAF is a signalling molecule1 that mediates interactions between cells2. Cell-cell interactions are critical in both physiologic and pathologic processes3,4. Many of the best-characterized effects of PAF involve cellular signalling in the inflammatory and vascular systems, but it also accomplishes signalling functions in the reproductive system, the brain, and in many other organs2. It has the remarkable property of being able to act as an endocrine, paracrine, autocrine, or juxtacrine signal depending on the cell of origin and the specific conditions under which it interacts with target cells5. The amphipathic properties of PAF and its ability to interact with both lipids and proteins contribute to this versatility.

Keywords

Human Endothelial Cell Adherent Neutrophil Juxtacrine Signalling Opsonized Zymosan Particle Mediate Neutrophil Adhesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zimmerman GA, Prescott SM and McIntyre TM. Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunology Today 1992; 13 (3): 93–100.PubMedCrossRefGoogle Scholar
  2. 2.
    Zimmerman GA, McIntyre TM, Prescott SM: Platelet-activating factor: A fluid-phase and cell-associated mediator of inflammation. In Inflammation: Basic Principles and Clinical Correlates, Second Edition. JI Gallin, IM Goldstein, R Snyderman, editors, Raven Press, New York, pp 149–176, 1992Google Scholar
  3. 3.
    Hynes RO and Lander AD. Contact and adhesive specificities in the associations, migrations and targeting of cells and axons. Cell 1992; 68: 303–322.PubMedCrossRefGoogle Scholar
  4. 4.
    Zimmerman GA, McIntyre TM and Prescott SM. Cell-to-cell communication. In The Lung: Scientific Foundations. Second Edition RG Crystal, JB West, ER Weibel, PJ Barnes, eds. Raven Press, in press 1995.Google Scholar
  5. 5.
    Zimmerman GA, Lorant DE, McIntyre TM and Prescott SM. Juxtacrine intercellular signaling: Another way to do it. Am J Resp Cell Mol Biol 1993; 9: 573–577.Google Scholar
  6. 6.
    Prescott SM, Zimmerman GA and McIntyre TM. Platelet-activating factor (PAF). J Biol Chem 1990; 265: 17381–17384.PubMedGoogle Scholar
  7. 7.
    Imaizumi T, Stafforini DM, Yamada Y, McIntyre TM, Prescott SM and Zimmerman GA. Platelet-activating factor: A mediator for clinicians. J Internal Med 1995; 238: 5–20.PubMedCrossRefGoogle Scholar
  8. 8.
    Prescott SM, Zimmerman GA and McIntyre TM: Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci USA 1984; 81: 3534–3538.PubMedCrossRefGoogle Scholar
  9. 9.
    McIntyre TM, Zimmerman GA and Prescott SM. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA 1986; 83: 2204–2208.PubMedCrossRefGoogle Scholar
  10. l0. Zimmerman GA, McIntyre TM and Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest 1985; 76: 2235–2246.CrossRefGoogle Scholar
  11. 11.
    Zimmerman GA, McIntyre TM, Mehra M and Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 1990; 110: 529–540.PubMedCrossRefGoogle Scholar
  12. 12.
    Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM and Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991; 115: 223–234.PubMedCrossRefGoogle Scholar
  13. 13.
    Geng J-G, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, Zimmerman GA and McEver RP. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343: 757–760.PubMedCrossRefGoogle Scholar
  14. 14.
    McEver RP. Leukocyte-endothelial cell interactions. Curr Opin Cell Biol 1992; 4: 840–849.PubMedCrossRefGoogle Scholar
  15. 15.
    Sako D, Chang X-J, Barone KM, Vachino G, White HM, Shaw G, Veldman GM, Bean KM, Ahern TJ, Furie B, Cumming DA and Larsen GR. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75: 1179–1186.PubMedCrossRefGoogle Scholar
  16. 16.
    Moore KL, Patel KD, Bruehl RE, Fugang L, Johnson DA, Lichenstein HS, Cummings RD, Bainton DF and McEver RP. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995; 128: 661–671.PubMedCrossRefGoogle Scholar
  17. 17.
    Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM and Zimmerman GA. Inflammatory roles of P-selectin. J Clin Invest 1993; 92: 559–570.PubMedCrossRefGoogle Scholar
  18. 18.
    Lorant DE, McEver RP, McIntyre TM, Moore KL, Prescott SM and Zimmerman GA. Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for Pselectin on their surfaces. J Clin Invest 1995; 96: 171–182.PubMedCrossRefGoogle Scholar
  19. 19.
    Vercellotti GM, Wickham NWR, Gustafson KS, Yin HQ, Herbert M and Jacob HS. Thrombin-treated endothelium primes neutrophil functions: inhibition by platelet-activating factor receptor antagonists. J Leukoc Biol 1989; 45: 483–490.PubMedGoogle Scholar
  20. 20.
    Ninio E, Leyravaud S, Bidault J, Jurgens P and Benveniste J. Cell adhesion by membrane-bound pafacether. International Immunology 1991; 3: 1157–1163.PubMedCrossRefGoogle Scholar
  21. 21.
    Kuijpers TW, Hakkert BC, Hart MHL and Roos D. Neutrophil migration across monolayers of cytokineprestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol 1992; 117: 565–572.PubMedCrossRefGoogle Scholar
  22. 22.
    Zhou W, Javors MA and Olson MS. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation. J Immunol 1992; 149: 1763–1769.PubMedGoogle Scholar
  23. 23.
    Macconi D, Foppolo M, Paris S, Noris M, Aiello S, Remuzzi G and Remuzzi A. PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress. Am J Physiol 1995; 269(Cell Physiol 38 ): C42–C47.Google Scholar
  24. 24.
    von Asmuth EJU and Buurman WA. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-a-induced H202 release by adherent neutrophil leukocytes. J Immunol 1995; 154: 1383–1390.Google Scholar
  25. 25.
    Anklesaria P, Texidò J, Laiho M, Pierce JH, Greenberger JS and Massagué J. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor a to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci 1990; 87: 3289–3293.PubMedCrossRefGoogle Scholar
  26. 26.
    Massagué J. Transforming growth factor-a. A model for membrane-anchored growth factors. J Biol Chem 1990; 265 (35): 21393–21396.PubMedGoogle Scholar
  27. 27.
    Patel KD, Zimmerman GA, Prescott SM and McIntyre TM. Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Biol Chem 1992; 267:1 5 1 68–1 5 1 75.Google Scholar
  28. 28.
    McIntyre TM, Patel KD, Smiley PL, Stafforini DM, Prescott SM and Zimmerman GA. Oxidized phospholipids with PAF-like bioactivity. J Lipid Mediators Cell Signalling 1994; 10: 37–39.Google Scholar
  29. 29.
    Weyrich AS, McIntyre TM, McEver RP, Prescott SM and Zimmerman GA. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-a secretion: Signal integration and NF-KB translocation. J Clin Invest 1995; 95: 2297–2303.PubMedCrossRefGoogle Scholar
  30. 30.
    Elstad MR, LaPine TR, Cowley FS, McEver RP, McIntyre TM, Prescott SM and Zimmerman GA. P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes. J Immunol 1995; 155: 2109–2122.PubMedGoogle Scholar
  31. 31.
    Kravchenko VV, Pan Z, Han J, Herbert J-M, Ulevitch RJ and Ye RD. Platelet-activating factor induces NF-KB activation through a G protein-coupled pathway. J Biol Chem 1995; 270: 14928–14934.PubMedCrossRefGoogle Scholar
  32. 32.
    Elstad MR, Prescott SM, McIntyre TM and Zimmerman GA. Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes. J Immunol 1988; 140: 1618–1624.PubMedGoogle Scholar
  33. 33.
    Elstad MR, Parker CJ, Cowley FS, Wilcox LA, McIntyre TM, Prescott SM and Zimmerman GA. CD] lb/CD18 integrin and a ß-glucan receptor act in concert to induce the synthesis of platelet-activation factor by monocytes. J Immunol 1994; 152: 220–230.PubMedGoogle Scholar
  34. 34.
    Coughlan AF, Hau H, Dunlop LC, Berndt MC, Hancock WW. P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med 1994; 179: 329–334.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • G. A. Zimmerman
    • 1
    • 4
  • M. R. Elstad
    • 1
    • 3
    • 4
  • D. E. Lorant
    • 1
    • 6
  • T. M. McIntyre
    • 1
    • 4
    • 5
  • S. M. Prescott
    • 2
    • 3
    • 4
  • Matthew K. Topham
    • 1
    • 4
  • A. S. Weyrich
    • 1
    • 4
  • Ralph E. Whatley
    • 1
    • 4
  1. 1.Nora Eccles Harrison Cardiovascular Research and Training InstituteUSA
  2. 2.Program in Human Molecular Biology and GeneticsUSA
  3. 3.Departments of BiochemistryUniversity of UtahSalt Lake CityUSA
  4. 4.Departments of MedicineUniversity of UtahSalt Lake CityUSA
  5. 5.Departments of PathologyUniversity of UtahSalt Lake CityUSA
  6. 6.Departments of PediatricsUniversity of UtahSalt Lake CityUSA

Personalised recommendations